SCHEMBL4124299

SCHEMBL4124299

CCOc1c(OC)cccc1C(=O)c1cc(Cl)ccc1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.50
RORC P51449 2/20 0.45
RORB Q92753 2/20 0.45
LMNA P02545 3/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALOX15 P16050 2/20 0.42
TSHR P16473 2/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42
KCNMA1 Q12791 1/20 0.42
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.41
FABP3 P05413 1/20 0.41
FABP4 P15090 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL635552 0.89 RECQL (0.56) RECQLRORCRORBLMNAKMT2A
SCHEMBL4117233 0.84 L3MBTL1 (0.41) LMNAMEN1KMT2AALOX15TSHR
SCHEMBL6953541 0.83 RECQL (0.60) RECQLLMNAMEN1KMT2AALOX15
SCHEMBL4115238 0.82 RECQL (0.52) RECQLRORCRORBLMNAALOX15
SCHEMBL4117946 0.82 RECQL (0.49) RECQLRORCRORBKCNMA1KCNK3
SCHEMBL4125266 0.82 RECQL (0.57) RECQLRORCRORBKCNMA1NOS2
SCHEMBL2705425 0.82 RECQL (0.65) RECQLRORCRORBLMNAALOX15
SCHEMBL4117553 0.81 RECQL (0.54) RECQLRORCRORBLMNAALOX15
SCHEMBL4132207 0.81 RECQL (0.56) RECQLRORCRORBKCNMA1NOS2
SCHEMBL4124662 0.81 RECQL (0.56) RECQLRORCRORBLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR RECQL 271/4885RORC 2588/4885RORB 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.